317 related articles for article (PubMed ID: 32865802)
21. The domestication of the African Union model law on medical products regulation: Perceived benefits, enabling factors, and challenges.
Ncube BM; Dube A; Ward K
Front Med (Lausanne); 2023; 10():1117439. PubMed ID: 36793874
[TBL] [Abstract][Full Text] [Related]
22. The Implementation of a Risk-Based Assessment Approach by the South African Health Products Regulatory Authority (SAHPRA).
Moeti L; Litedu M; Joubert J
Pharmaceut Med; 2023 Jan; 37(1):71-91. PubMed ID: 36598646
[TBL] [Abstract][Full Text] [Related]
23. Can Standardisation of the Public Assessment Report Improve Benefit-Risk Communication?
Keyter A; Salek S; Banoo S; Walker S
Front Pharmacol; 2020; 11():855. PubMed ID: 32625087
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the Food and Drugs Authority, Ghana Regulatory Review Process: Challenges and Opportunities.
Owusu-Asante M; Darko DM; Asamoah-Okyere KD; Asante-Boateng S; Kermad A; Walker S; Salek S
Ther Innov Regul Sci; 2023 Mar; 57(2):372-385. PubMed ID: 36352343
[TBL] [Abstract][Full Text] [Related]
25. Worldwide Regulatory Reliance: Launching A Pilot on A Chemistry, Manufacturing and Control Post Approval Change for A Vaccine.
Gastineau T; Ban C; Basso A; Brehme F; Silva AL; Faure O; Le Palaire L; Persaud P; Rodriguez H
PDA J Pharm Sci Technol; 2023 Nov; ():. PubMed ID: 37973190
[TBL] [Abstract][Full Text] [Related]
26. Medicines Regulatory Science Expertise in Africa: Workforce Capacity Development and Harmonisation Activities Towards the Establishment of the African Medicines Agency.
Ncube BM; Dube A; Ward K
Pharmaceut Med; 2022 Apr; 36(2):83-97. PubMed ID: 35380413
[TBL] [Abstract][Full Text] [Related]
27. Regulatory reliance pathways during health emergencies: enabling timely authorizations for COVID-19 vaccines in Latin America.
van der Zee IT; Vreman RA; Liberti L; Garza MA
Rev Panam Salud Publica; 2022; 46():e115. PubMed ID: 36060200
[TBL] [Abstract][Full Text] [Related]
28. The process of ratifying the treaty to establish the African Medicines Agency: perspectives of national regulatory agencies.
Ncube BM; Dube A; Ward K
Health Policy Plan; 2024 May; 39(5):447-456. PubMed ID: 38497780
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the registration process of the medicines control authority of Zimbabwe with Australia, Canada, Singapore, and Switzerland: benchmarking best practices.
Sithole T; Salek S; Mahlangu G; Walker S
Expert Rev Clin Pharmacol; 2022 Jan; 15(1):109-119. PubMed ID: 34645359
[TBL] [Abstract][Full Text] [Related]
30. WHO collaborative registration procedure using stringent regulatory authorities' medicine evaluation: reliance in action?
Vaz A; Roldão Santos M; Gwaza L; Mezquita González E; Pajewska Lewandowska M; Azatyan S; Saint-Raymond A
Expert Rev Clin Pharmacol; 2022 Jan; 15(1):11-17. PubMed ID: 35130803
[TBL] [Abstract][Full Text] [Related]
31. A Mixed Methods Study to Explore Relevant Metrics for a Results Framework Measuring the Public Health Impact of Reliance-Based Pathways.
Adams I; Cuff PA; Liberti L
Ther Innov Regul Sci; 2023 Nov; 57(6):1260-1268. PubMed ID: 37552399
[TBL] [Abstract][Full Text] [Related]
32. Primary Care Research Team Assessment (PCRTA): development and evaluation.
Carter YH; Shaw S; Macfarlane F
Occas Pap R Coll Gen Pract; 2002 Feb; (81):iii-vi, 1-72. PubMed ID: 12049028
[TBL] [Abstract][Full Text] [Related]
33. Asia Partnership Conference of Pharmaceutical Associations (APAC) Report on Regulatory Agility Implemented During the COVID-19 Pandemic: Inspiring Partnerships and Recommendations for the Way Forward.
Chong SSF; Kanno M; Chee ASM; Long SM; Ong SHM; Harnpramukkul U; Binos RSR
Ther Innov Regul Sci; 2023 Jan; 57(1):12-25. PubMed ID: 36175790
[TBL] [Abstract][Full Text] [Related]
34. National guidance and district-level practices in the supervision of community health workers in South Africa: a qualitative study.
Assegaai T; Schneider H
Hum Resour Health; 2019 Apr; 17(1):25. PubMed ID: 30943986
[TBL] [Abstract][Full Text] [Related]
35. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report.
Coons SJ; Gwaltney CJ; Hays RD; Lundy JJ; Sloan JA; Revicki DA; Lenderking WR; Cella D; Basch E;
Value Health; 2009 Jun; 12(4):419-29. PubMed ID: 19900250
[TBL] [Abstract][Full Text] [Related]
36. Reliance: a smarter way of regulating medical products - The IPRP survey.
Doerr P; Valentin M; Nakashima N; Orphanos N; Santos G; Balkamos G; Saint-Raymond A
Expert Rev Clin Pharmacol; 2021 Feb; 14(2):173-177. PubMed ID: 33355025
[No Abstract] [Full Text] [Related]
37. Research evidence and policy: qualitative study in selected provinces in South Africa and Cameroon.
Naude CE; Zani B; Ongolo-Zogo P; Wiysonge CS; Dudley L; Kredo T; Garner P; Young T
Implement Sci; 2015 Sep; 10():126. PubMed ID: 26334760
[TBL] [Abstract][Full Text] [Related]
38. Sharing regulatory data as tools for strengthening health systems in the Region of the Americas.
Sousa VD; Ramalho PI; Silveira D
Rev Panam Salud Publica; 2016 May; 39(5):245-254. PubMed ID: 27706398
[TBL] [Abstract][Full Text] [Related]
39. The Implementation of the 2020 Roadmap to Promote Good Registration Management (GRM) in APEC Region.
Lin HY; Huang YH; Cheng SY; Lin YJ; Liu CP; Huang CL; Lin CL
Ther Innov Regul Sci; 2021 Jul; 55(4):872-880. PubMed ID: 33904126
[TBL] [Abstract][Full Text] [Related]
40. Pharmacovigilance in India, Uganda and South Africa with reference to WHO's minimum requirements.
Maigetter K; Pollock AM; Kadam A; Ward K; Weiss MG
Int J Health Policy Manag; 2015 Mar; 4(5):295-305. PubMed ID: 25905480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
